Go to the list of all blogs
Allana's Avatar
published in Blogs
Jul 23, 2026
Why Is Liberty Energy Inc. (LBRT) Stock Down -15.63% Today?

Why Is Liberty Energy Inc. (LBRT) Stock Down -15.63% Today?

Key Takeaways

  • Liberty Energy shares plunged 15.63% to $21.21 on Thursday, erasing weeks of gains in a single session despite the company topping Wall Street's second-quarter revenue and EPS estimates.
  • The primary catalyst was a sharp deterioration in profitability metrics — net income fell 40% year-over-year, adjusted EBITDA dropped 16%, and operating margin compressed to 1.1% from 3.6% a year ago, overshadowing the top-line beat.
  • A Zacks Research downgrade from "Strong-Buy" to "Hold" added selling pressure, reflecting analyst unease about Liberty's earnings trajectory even as management touted strategic data center and power-generation initiatives.
  • Broader market weakness amplified the sell-off, with the S&P 500 dropping 0.8% and the Nasdaq falling 1.6% as surging oil prices — Brent crude topped $100 per barrel — stoked inflation fears and weighed on risk appetite.
  • Traders are now focused on whether Liberty's data center pivot can offset cyclical pressure in its core hydraulic fracturing business, and whether energy-sector demand holds up amid escalating Middle East tensions.

Opening Summary

LBRT, the stock of Liberty Energy Inc. — a Denver-based integrated energy services and technology company and one of North America's largest providers of hydraulic fracturing services — suffered a punishing 15.63% decline on Thursday. The stock closed the session at $21.21, down from a prior close of $25.14, as investors reacted with dismay to second-quarter results that, while beating consensus estimates on revenue and adjusted earnings per share, revealed a steep erosion in year-over-year profitability. The selling accelerated through the day, reversing an initially positive after-hours reaction to the earnings release and marking one of the stock's worst single-day performances in recent memory.

Q2 Earnings: A Revenue Beat That Masked Profit Weakness

Liberty Energy reported second-quarter 2026 results after the market close on Wednesday, July 22. On the surface, the numbers appeared constructive: revenue of $1.19 billion sailed past the $1.09 billion analyst consensus, rising 14% year-over-year, while adjusted earnings per share of $0.09 edged out the $0.08 estimate. The company also highlighted a slate of forward-looking strategic announcements, including a joint venture with PowerBridge LLC targeting gigawatt-scale data center campuses, a strategic alliance with SLB for modular power infrastructure, and the formation of Liberty Wholesale Commodities to participate directly in ERCOT power markets.

However, a deeper look at the income statement revealed significant deterioration. Net income tumbled to $43 million from $71 million in the same quarter a year ago — a 40% decline. Adjusted EBITDA of $151 million represented a 16% year-over-year contraction, and the company's adjusted net income of $14 million compared unfavorably to $20 million in the prior-year period. Perhaps most alarming to investors was the collapse in operating margin, which narrowed to just 1.1% from 3.6% a year ago, signaling meaningful cost pressures and pricing headwinds in Liberty's core completions business. The conference call held Thursday morning likely compounded these concerns, with management commentary around near-term demand visibility failing to reassure an already nervous market.

Analyst Downgrade Compounds Selling Pressure

Adding fuel to the sell-off, Zacks Research downgraded LBRT from a "Strong-Buy" rating to a "Hold" rating on Thursday. The downgrade came despite Liberty's revenue beat and reflected growing caution about the sustainability of earnings in a market where frac activity faces persistent cyclical headwinds. While the broader analyst community maintains a "Moderate Buy" consensus with an average price target near $32, the Zacks reversal underscored a shifting sentiment narrative. The downgrade also drew attention to recent insider selling activity — including stock sales by CFO Michael Stock and Chairman William F. Kimble totaling approximately $1.67 million over the prior 90 days — which may have further unsettled retail and institutional holders.

Broader Market and Macro Crosscurrents

Thursday's trading session was hostile to equities across the board, amplifying Liberty's stock-specific troubles. The S&P 500 shed 0.8%, the Dow Jones Industrial Average dropped 363 points, and the tech-heavy Nasdaq Composite tumbled 1.6%, dragged lower by post-earnings routs in TSLA and GOOGL. Oil prices, meanwhile, surged dramatically — Brent crude briefly crossed $100 per barrel for the first time in two months as escalating hostilities between the United States and Iran, coupled with Houthi attacks on Saudi oil tankers in the Red Sea, raised the specter of simultaneous disruptions at both the Strait of Hormuz and the Bab el-Mandeb chokepoints. While rising crude prices are typically a tailwind for energy services names, Thursday's oil spike was driven by geopolitical supply fears that also stoked broader inflation anxieties, pushing the 10-year Treasury yield to 4.70% and sending risk assets broadly lower. For LBRT, the macro headwinds appeared to outweigh any commodity-price benefit.

Market Context and Trading Activity

Trading volume in LBRT was notably elevated, far exceeding the stock's recent daily averages as institutional and algorithmic participants aggressively repositioned. The intraday price action was particularly brutal: after opening near $25.53 — modestly above the prior close — shares quickly reversed course, slicing through multiple support levels including the psychologically important $24 and $23 handles before settling near session lows at $21.21. The 50-day simple moving average, which had been around $27.78, was decisively breached, as was the 200-day moving average near $27.21, leaving the stock in technically oversold territory but with no clear near-term floor. Sector peers in oilfield services also traded lower, though Liberty's decline was disproportionate, suggesting that company-specific worries about margin compression and the earnings trajectory dominated the price action.

Trending AI Robots

In volatile market environments like today's, identifying actionable trading opportunities can be especially challenging. Tickeron offers hundreds of AI-powered trading bots that scan thousands of tickers across all market sectors, using sophisticated algorithms to analyze technical patterns, fundamental data, and momentum signals. However, only the strongest-performing bots under current market conditions are featured in the curated Trending AI Robots section. These bots vary by trading strategy, time horizon, performance metrics, and the specific symbols they trade, allowing users to find approaches aligned with their own objectives. For traders seeking a data-driven edge in navigating fast-moving stocks like LBRT, exploring the Trending AI Robots page may offer a helpful starting point.

What Comes Next for LBRT

The road ahead for Liberty Energy hinges on several key variables. In the near term, the market will be closely parsing any follow-through analyst revisions and digesting the full transcript of Thursday's conference call for clues about third-quarter guidance and the demand outlook for hydraulic fracturing services across North American shale basins. Liberty's strategic pivot toward power generation and data center infrastructure — including the PowerBridge joint venture and the SLB alliance — represents a potentially transformative long-term growth vector, but meaningful revenue contribution from these initiatives is not expected until late 2027 at the earliest. In the interim, the company remains exposed to the cyclical rhythms of E&P capital spending, which could be pressured if elevated oil prices begin to crimp global economic activity and, by extension, hydrocarbon demand. Geopolitical developments in the Middle East, Federal Reserve policy responses to resurgent inflation fears, and the trajectory of U.S. drilling activity will all play critical roles in shaping sentiment around LBRT in the weeks and months ahead.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: LBRT

Contributor

Allana's AvatarAllana|Expert

Financial analyst and market blogger with expertise in equity research, fundamental analysis, and macroeconomic trends. I regularly publish coverage on individual stocks, ETFs, and sector developments — combining rigorous financial analysis with clear, engaging writing for a broad investment audience.


LBRT's MACD Histogram just turned positive

The Moving Average Convergence Divergence (MACD) for LBRT turned positive on August 05, 2026. Looking at past instances where LBRT's MACD turned positive, the stock continued to rise in of 48 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where LBRT's RSI Indicator exited the oversold zone, of 19 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 62 cases where LBRT's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on August 06, 2026. You may want to consider a long position or call options on LBRT as a result. In of 88 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where LBRT advanced for three days, in of 319 cases, the price rose further within the following month. The odds of a continued upward trend are .

LBRT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where LBRT declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for LBRT entered a downward trend on August 05, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.665) is normal, around the industry mean (3.684). P/E Ratio (27.081) is within average values for comparable stocks, (83.385). LBRT's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.631). Dividend Yield (0.018) settles around the average of (0.018) among similar stocks. P/S Ratio (0.792) is also within normal values, averaging (2.190).

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. LBRT’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. LBRT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 66, placing this stock worse than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

Notable companies

The most notable companies in this group are SLB Limited (NYSE:SLB), Halliburton Company (NYSE:HAL).

Industry description

The oilfield services/equipment industry is involved in providing various equipment and services to oil and natural gas producers. These companies rent drilling rigs and/or provide services to build and maintain oil and gas wells. The performance of this industry is dependent on demand for oil and natural gas, which in turn is often driven by macroeconomic conditions or business cycles. Schlumberger NV, Halliburton Company, and Baker Hughes are some of the biggest oilfield services companies.

Market Cap

The average market capitalization across the Oilfield Services/Equipment Industry is 6.08B. The market cap for tickers in the group ranges from 43.89 to 76.49B. SLB holds the highest valuation in this group at 76.49B. The lowest valued company is KEGX at 43.89.

High and low price notable news

The average weekly price growth across all stocks in the Oilfield Services/Equipment Industry was 1%. For the same Industry, the average monthly price growth was -3%, and the average quarterly price growth was 53%. FTK experienced the highest price growth at 56%, while RCON experienced the biggest fall at -88%.

Volume

The average weekly volume growth across all stocks in the Oilfield Services/Equipment Industry was 11%. For the same stocks of the Industry, the average monthly volume growth was 38% and the average quarterly volume growth was -11%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 55
P/E Growth Rating: 33
Price Growth Rating: 49
SMR Rating: 76
Profit Risk Rating: 66
Seasonality Score: -8 (-100 ... +100)
View a ticker or compare two or three
LBRT
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a oilfield service company which provides specialized stimulation services to optimize well production

Industry OilfieldServicesEquipment

Profile
Details
Industry
Oilfield Services Or Equipment
Address
950 17th Street
Phone
+1 303 515-2800
Employees
5500
Web
https://www.libertyenergy.com
Interact to see
Advertisement
Novartis (NVS) reports Q4/FY 2025 earnings on February 4, 2026, with consensus calling for ~$1.99 EPS on ~$13.7 billion in revenue. Sanofi (SNY) delivered strong FY 2025 results on January 29, reporting €43.6 billion in sales (+9.9% CER) and 15% business EPS growth.
Novo Nordisk (NVO) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $11.96 billion in revenue and $0.89 EPS, reflecting a moderation in GLP-1 growth. Eli Lilly (LLY) is expected to report around the same time, with projections of $17.87 billion in revenue and $6.99 EPS, driven by continued volume gains from Mounjaro and Zepbound.
MUFG is expected to report Q3 FY2026 EPS of about $0.30, broadly in line with its recent pattern of earnings beats.
Banco Santander (SAN) reports Q4 2025 earnings on February 4, 2026, following record nine-month attributable profit of €10.3 billion, up 11% year over year.
Uber (UBER) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $0.78 EPS and $14.32 billion in revenue, up about 20% year over year.
Qualcomm’s Q1 FY2026 report, covering the period ended December 28, 2025, arrives amid a pivotal shift in the semiconductor landscape. While handset growth moderates, the company is expanding in automotive, IoT, and AI-enabled devices.
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
Boston Scientific’s Q4 caps a transformative year, driven by ~15.5% organic growth from WATCHMAN, FARAPULSE electrophysiology, and MedSurg expansions. As a leader in minimally invasive devices, BSX’s results set the benchmark against Medtronic and Stryker—diversified medtech giants navigating tariffs, procedural rebounds, and innovation.
Arm, the leading provider of energy-efficient processor designs powering over 99% of smartphones and expanding into AI data centers, faces high scrutiny in Q3 FY2026 (ending Dec 31, 2025). After a strong Q2 with record royalty and licensing revenue, investors are focused on whether AI demand will continue to drive robust growth.
CME Group (CME): Q4 2025 earnings due February 4, 2026; consensus expects adjusted EPS $2.75 and revenue ~$1.6B. S&P Global (SPGI): Q4 2025 earnings due February 10, 2026; Q3 posted EPS $4.73 and 9% revenue growth, driven by Ratings, Indices, and Market Intelligence.
Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.
Starbucks shares have shown renewed strength in recent trading, rebounding from earlier lows within a 52-week range of $75.50 to $117.46. The recovery reflects improving comparable sales trends and a return to transaction growth, suggesting early progress from operational initiatives aimed at reconnecting with customers.
DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.
Amazon’s Q4 report capped a strong year marked by accelerating cloud growth, steady retail execution, and expanding advertising profitability. The results reinforced Amazon’s positioning as a core beneficiary of enterprise AI demand, particularly through AWS, while highlighting improving operating leverage across the broader business.
ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.
ICE reported Q4 2025 net revenues of $2.5 billion, up 8% year-over-year, capping 20 consecutive years of record annual revenues at $9.9 billion.
Eli Lilly’s Q4 results highlight explosive growth from GLP-1 therapies, cementing leadership in obesity and diabetes. The company’s strong revenue beat and robust 2026 guidance illustrate high-growth pharma dynamics. Johnson & Johnson, in contrast, exemplifies a diversified healthcare strategy, combining pharmaceuticals, MedTech, and consumer health for steady expansion.
Eli Lilly (LLY), AbbVie (ABBV), and Merck (MRK) all reported strong Q4 2025 earnings, but the market reacted differently to each, reflecting variations in growth profiles, product concentration, and sector dynamics. AbbVie delivered Q4 revenue of $16.62 billion, up 10% year-over-year, with full-year revenue reaching $61.2 billion, an 8.6% increase. Adjusted EPS came in at $2.71, surpassing consensus, though shares dipped following the report amid ongoing Humira concerns
Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.
MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.